Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Tamoxifen and SUBA-Itraconzole Combination Testing in Ovarian Cancer [Phase 1]
Phase 1 trial testing a combination of tamoxifen and SUBA-itraconazole for ovarian cancer; the study is listed as active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Phase II Study of Utidelone Plus Fruquintinib Combination Therapy for Platinum-Resistant Recurrent Ovarian Cancer [Phase 2]
A Phase II clinical trial is evaluating the combination of utidelone and fruquintinib for platinum-resistant recurrent ovarian cancer; the s…
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Continued Access to RXDX-105 [Phase 1]
This clinical trial update concerns continued access to RXDX-105 in a Phase 1 study for non-small cell lung cancer and ovarian cancer, inclu…
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Performance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy
This clinical trial update compares SYMMCORA and V-Loc barbed sutures in patients undergoing laparoscopic total hysterectomy, with recruitme…
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer [Phase 2, Phase 3]
Results from a Phase 2/3 trial evaluating the combination of cediranib and olaparib versus each drug alone or chemotherapy in recurrent plat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer [Phase 2, Phase 3]
Phase 2/3 trial updating the combination of cediranib and olaparib versus each drug alone or other chemotherapy in recurrent platinum-resist…
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: A Study of PF-07260437 in Advanced or Metastatic Solid Tumors [Phase 1]
A Phase 1 study of PF-07260437 in advanced or metastatic solid tumors was terminated, with results posted on 2025-05-06.
-
CLINICAL_TRIALS research · 2025-05-06Clinical Trial Update: Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI's Pan-tumor Priority Study is an observational cancer study that is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-05-06Clinical Trial Update: Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
This clinical trial update describes a Stanford-sponsored study investigating BRCA1/BRCA2-associated tumors and the collection of related tu…
-
CLINICAL_TRIALS research · 2025-05-04Clinical Trial Update: Niraparib and Neratinib in Advanced Solid Tumors With Expansion Cohort in Advanced Ovarian Cancer [Phase 1]
Phase 1 clinical trial update evaluating the combination of niraparib and neratinib in advanced solid tumors with an expansion cohort in ova…
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: A Study of LY2880070 in Participants With Advanced or Metastatic Cancer [Phase 1, Phase 2]
Esperas Pharma completed a Phase 1/2 study of LY2880070 in adults with advanced or metastatic cancer, including colorectal cancer.
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating AMXI-5001 in patients with advanced cancers, including breast, ovarian, prostate, and pancreatic cance…
-
CLINICAL_TRIALS trial_result · 2025-04-30Clinical Trial Update: Study of Relacorilant in Combination With Nab-Paclitaxel for Patients With Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial of relacorilant with nab-paclitaxel in recurrent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer has …
-
CLINICAL_TRIALS research · 2025-04-30Clinical Trial Update: IN10018 in Combination With Pegylated Liposomal Doxorubicin (PLD) vs. Placebo in Combination With PLD for the Treatment of Platinum-resistant Recurrent Ovarian Cancer [Phase 2]
A Phase 2 trial evaluating IN10018 in combination with pegylated liposomal doxorubicin versus PLD with placebo in platinum-resistant recurre…
-
CLINICAL_TRIALS research · 2025-04-30Clinical Trial Update: IN10018 in Combination With Standard Chemotherapy in High-grade Serous Epithelial Ovarian Cancer [Phase 1, Phase 2]
A Phase 1/2 trial (IN10018) evaluating IN10018 in combination with standard chemotherapy for high-grade serous epithelial ovarian cancer is …
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors [NA]
A completed clinical trial evaluating the Carevive Survivor Care Planning System for improving quality of life in breast cancer survivors.
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: CAR T Cells in Mesothelin Expressing Cancers [Phase 1]
Phase 1 study evaluating mesothelin-targeted CAR T cells in mesothelin-expressing cancers; results have been posted for a University of Penn…
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: Prehabilitation During the Neoadjuvant Window of Opportunity in Older Women With Ovarian Cancer [NA]
The study examines prehabilitation during the neoadjuvant window in older women with ovarian cancer, and the trial status is completed.
-
CLINICAL_TRIALS research · 2025-04-29Clinical Trial Update: Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment) [NA]
A clinical trial update for a physical activity intervention (Fit4Treatment) in older women with gynecologic cancers, currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-27Clinical Trial Update: Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics [NA]
Emory University is conducting a study to evaluate an evidence-based family history screening program designed to increase uptake of BRCA-as…
-
CLINICAL_TRIALS research · 2025-04-27Clinical Trial Update: SBRT-LDRT-Cadonilimab for Advanced Gastric, Colorectal and Ovarian Cancers With Peritoneal Metastases [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluating SBRT-LDRT with cadonilimab for advanced gastric, colorectal, and ovarian cancers with peritoneal…
-
CLINICAL_TRIALS research · 2025-04-25Clinical Trial Update: First-in-human Interleukin-15-transpresenting Wilms' Tumor Protein 1-targeting Autologous Dendritic Cell Vaccination in Cancer Patients [Phase 1, Phase 2]
First-in-human Phase 1/2 trial of an autologous dendritic cell vaccine targeting Wilms' tumor protein 1 (WT1) with interleukin-15 trans-pres…
-
CLINICAL_TRIALS research · 2025-04-23Clinical Trial Update: Evolution of the Therapeutic Care in Ovarian Cancer From 2011
This update notes that the UNICANCER-sponsored ovarian cancer trial NCT03275298 is currently suspended, reflecting an ongoing reassessment o…
-
CLINICAL_TRIALS trial_result · 2025-04-23Clinical Trial Update: Geriatric Assessment and Nursing Telephone Intervention in Elderly Women With Ovarian Cancer
This update notes the completion of a clinical trial evaluating geriatric assessment plus nursing telephone support for elderly women with o…
-
CLINICAL_TRIALS research · 2025-04-23Clinical Trial Update: Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) in Relapse Ovarian Cancer Treatment [Phase 3]
This clinical trial update reports a Phase 3 study evaluating hyperthermic intraperitoneal chemotherapy (HIPEC) for relapsed ovarian epithel…